JP2020504122A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504122A5 JP2020504122A5 JP2019535810A JP2019535810A JP2020504122A5 JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5 JP 2019535810 A JP2019535810 A JP 2019535810A JP 2019535810 A JP2019535810 A JP 2019535810A JP 2020504122 A5 JP2020504122 A5 JP 2020504122A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- optionally substituted
- aryl
- heteroaryl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 Chemical compound Cc(cc1)ccc1N/C1=C\C*/C(/CC(CCCC2)CCN2c2cc(OC)ccc2)=N/C(/N)=N1 0.000 description 5
- AQJLZOXYUHCQCV-UHFFFAOYSA-N CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 Chemical compound CC(CCCc1ccc(C)cc1)CCc1nc(N)nc(Nc2ccccc2C)n1 AQJLZOXYUHCQCV-UHFFFAOYSA-N 0.000 description 2
- JUCGCZDYNSFCKZ-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CC2CCOCCCC2)nc(N)n1 JUCGCZDYNSFCKZ-UHFFFAOYSA-N 0.000 description 1
- QYJQPVDGBPGYEX-UHFFFAOYSA-N Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 Chemical compound Cc(cc1)ccc1Nc1nc(CN(CC2)c3c2cccc3)nc(N)n1 QYJQPVDGBPGYEX-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382672.0 | 2016-12-29 | ||
| EP16382672 | 2016-12-29 | ||
| PCT/IB2017/058477 WO2018122775A1 (en) | 2016-12-29 | 2017-12-28 | Heteroaryl compounds and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504122A JP2020504122A (ja) | 2020-02-06 |
| JP2020504122A5 true JP2020504122A5 (enExample) | 2021-02-12 |
| JP7171057B2 JP7171057B2 (ja) | 2022-11-15 |
Family
ID=57708486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019535810A Active JP7171057B2 (ja) | 2016-12-29 | 2017-12-28 | ヘテロアリール化合物およびその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11174242B2 (enExample) |
| EP (1) | EP3562811B1 (enExample) |
| JP (1) | JP7171057B2 (enExample) |
| CN (1) | CN110325516A (enExample) |
| AU (1) | AU2017388466B2 (enExample) |
| BR (1) | BR112019013571A2 (enExample) |
| CA (1) | CA3048357A1 (enExample) |
| IL (1) | IL267626B2 (enExample) |
| WO (1) | WO2018122775A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325516A (zh) | 2016-12-29 | 2019-10-11 | 米尼奥尔克斯治疗有限公司 | 杂芳基化合物和它们的用途 |
| WO2020104578A2 (en) * | 2018-11-21 | 2020-05-28 | University Of Copenhagen | Modulators of free fatty acid receptor 1 and their use for treatment of diseases |
| AU2020394602A1 (en) * | 2019-11-25 | 2022-06-30 | Gt Gain Therapeutics Sa | Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidase |
| US20230103407A1 (en) * | 2020-03-10 | 2023-04-06 | University Of Cincinnati | Materials and methods for the treatment of gaucher disease |
| CN117659017A (zh) * | 2022-08-25 | 2024-03-08 | 北京华益健康药物研究中心 | Trpml1/2调节剂化合物、药物组合物及其制备方法和应用 |
| EP4676474A2 (en) * | 2023-03-24 | 2026-01-14 | Purdue Research Foundation | Symmetric aminoindole-linked triazine for a dual effect on alpha-synuclein and tau isoform 2n4r fibrillization |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE455106T1 (de) * | 1999-01-22 | 2010-01-15 | Elan Pharm Inc | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen |
| CN1486302A (zh) | 2000-12-07 | 2004-03-31 | CV���ƹ�˾ | 作为抗冠状动脉疾病或动脉硬化的abca-1加强化合物的取代1,3,5-三嗪和嘧啶 |
| US20030078271A1 (en) | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| CA2671776C (en) * | 2001-01-31 | 2012-12-18 | H. Lundbeck A/S | Gal3 receptor antagonists for the treatment of depression |
| EP1470121B1 (en) | 2002-01-23 | 2012-07-11 | Bayer HealthCare LLC | Pyrimidine derivatives as rho-kinase inhibitors |
| ES2273047T3 (es) | 2002-10-28 | 2007-05-01 | Bayer Healthcare Ag | Fenilaminopirimidinas sustituidas con heteroariloxi como inhibidores de rho-cinasa. |
| CN1199946C (zh) | 2002-10-29 | 2005-05-04 | 无锡杰西医药科技有限公司 | 一种特异性吲哚类化合物及制备方法与其在治疗和预防癌症等疾病中的应用 |
| WO2006110763A1 (en) | 2005-04-08 | 2006-10-19 | Bayer Pharmaceuticals Corporation | Pyrimidine derivatives and their use for the treatment of cancer |
| CA2622372A1 (en) | 2005-09-13 | 2007-03-22 | Palau Pharma, S.A. | 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| JP5337405B2 (ja) | 2007-09-17 | 2013-11-06 | ザ・ホスピタル・フォー・シック・チルドレン | ゴーシェ病の治療方法 |
| US8138356B2 (en) | 2007-10-16 | 2012-03-20 | Angiogeney, Inc. | Chemical inhibitors of inhibitors of differentiation |
| WO2009086303A2 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| US20130023498A1 (en) * | 2008-02-20 | 2013-01-24 | The Wistar Institute and North Carolina State University | MicroRNA Modulators and Method for Identifying and Using the Same |
| JP5767965B2 (ja) | 2008-06-10 | 2015-08-26 | プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． | キナーゼを調節する５ｈ−ピロロ［２，３−ｂ］ピラジン誘導体、およびその適応症 |
| SI2995306T1 (sl) | 2009-10-19 | 2019-04-30 | Amicus Therapeutics, Inc. | Novi sestavki za preprečevanje in/ali zdravljenje motenj lizosomskega shranjevanja |
| WO2012035055A1 (en) | 2010-09-17 | 2012-03-22 | Glaxo Group Limited | Novel compounds |
| KR101987736B1 (ko) | 2011-03-18 | 2019-06-11 | 젠자임 코포레이션 | 글루코실세라마이드 합성효소 억제제 |
| CA2840224C (en) | 2011-06-22 | 2019-08-13 | The General Hospital Corporation | Treatment of proteinopathies |
| US8961959B2 (en) | 2011-10-17 | 2015-02-24 | The Regents Of The University Of Michigan | Glucosylceramide synthase inhibitors and therapeutic methods using the same |
| CA2868459A1 (en) | 2012-03-27 | 2013-10-03 | Amicus Therapeutics, Inc. | Polymorphs of (3r,4r,5s)-5-(difluoromethyl)piperidine-3,4-diol fumarate and uses thereof |
| CN104918616A (zh) * | 2012-10-24 | 2015-09-16 | 格卢科克斯生物科技有限公司 | 用于治疗与烟酰胺腺嘌呤二核苷酸磷酸氧化酶相关的病况的三嗪衍生物 |
| WO2015014900A1 (en) | 2013-07-31 | 2015-02-05 | Minoryx Therapeutics S.L. | Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereof |
| AU2015217185B2 (en) | 2014-02-12 | 2018-04-05 | Purdue Pharma L.P. | Isoquinoline derivatives and use thereof |
| EP4406616A3 (en) | 2014-11-06 | 2024-11-06 | Bial-R&D Investments, S.A. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
| WO2016120808A1 (en) | 2015-01-28 | 2016-08-04 | Minoryx Therapeutics S.L. | Heteroarylaminoisoquinolines, methods for their preparation and therapeutic uses thereof |
| JP2018505226A (ja) | 2015-02-16 | 2018-02-22 | グルコックス・バイオテック・アーベー | Ｎ２−（３，４−ジメチルフェニル）−６−（（４−（ｐ−トリル）ピペラジン−１−イル）メチル）−１，３，５−トリアジン−２，４−ジアミン |
| MA42189A (fr) | 2015-04-15 | 2018-04-18 | Biomarin Pharm Inc | Mã‰thodes de traitement des troubles du stockage lysosomal |
| US10308656B2 (en) | 2015-08-18 | 2019-06-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Small molecule inhibitors of Ku70/80 and uses thereof |
| CN105412114A (zh) | 2015-12-11 | 2016-03-23 | 卢璐娇 | 6-{[4-(2-氟苯基)1-哌嗪基]甲基}-n-(萘基)-1,3,5-三嗪-2,4-二胺在制备血管生成抑制剂中的应用 |
| CN110325516A (zh) | 2016-12-29 | 2019-10-11 | 米尼奥尔克斯治疗有限公司 | 杂芳基化合物和它们的用途 |
-
2017
- 2017-12-28 CN CN201780086577.0A patent/CN110325516A/zh active Pending
- 2017-12-28 JP JP2019535810A patent/JP7171057B2/ja active Active
- 2017-12-28 AU AU2017388466A patent/AU2017388466B2/en not_active Ceased
- 2017-12-28 WO PCT/IB2017/058477 patent/WO2018122775A1/en not_active Ceased
- 2017-12-28 EP EP17829719.8A patent/EP3562811B1/en active Active
- 2017-12-28 BR BR112019013571-5A patent/BR112019013571A2/pt not_active IP Right Cessation
- 2017-12-28 US US16/474,461 patent/US11174242B2/en active Active
- 2017-12-28 CA CA3048357A patent/CA3048357A1/en active Pending
-
2019
- 2019-06-25 IL IL267626A patent/IL267626B2/en unknown
-
2021
- 2021-10-06 US US17/495,542 patent/US11739072B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504122A5 (enExample) | ||
| AU2016299485B2 (en) | 1,3,4-oxadiazole amide derivative compound as histone deacetylase 6 inhibitor, and pharmaceutical composition containing same | |
| EP2429292B1 (en) | Compounds and compositions comprising cdk inhibitors and their use in the treatment of cancer | |
| JP2020519606A5 (enExample) | ||
| JP2020504711A5 (enExample) | ||
| JP2016534134A5 (enExample) | ||
| JP2020503297A5 (enExample) | ||
| JP2022549222A5 (enExample) | ||
| BR0014649A (pt) | Utilização de um produto, medicamento, composto e composição farmacêutica | |
| HUP0401876A2 (hu) | Béta2 adrenerg receptor agonista hatású aril-anilin-származékok, valamint ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| JPH11193281A (ja) | アデノシンａ３受容体拮抗剤およびチアゾール化合物 | |
| NO900991D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater | |
| JP2008513515A5 (enExample) | ||
| AR089134A1 (es) | Arilos y heteroarilos biciclicos inhibidores de los canales de sodio | |
| JP2005513026A5 (enExample) | ||
| RU2005117789A (ru) | Производные 4,5-диарилтиазола в качестве лигандов св-1 | |
| JP2020533352A5 (enExample) | ||
| RU2017145930A (ru) | МОДУЛЯТОРЫ ROR ГАММА (RORγ) | |
| BR112023025599A2 (pt) | Ativadores de dimetoxifenilalquilamina de receptores de serotonina. | |
| JP2013542267A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| JPWO2023195529A5 (enExample) | ||
| CA2730471A1 (en) | Piperazine derivatives used as cav2.2 calcium channel modulators | |
| CA2618511A1 (en) | Novel benzothiazolone derivatives | |
| CA2405408A1 (en) | Pyrazole compounds |